Read Dr. Folkman's
Acceptance Speech
(May 2, 2006 - 36K PDF)
|
Judah Folkman, M.D. is the founder of the field of angiogenesis research. He has made seminal discoveries on the mechanism of angiogenesis which have opened a field of investigation now pursued worldwide.
Dr. Folkman’s hypothesis (1971) that solid tumors are angiogenesis-dependent initiated studies of angiogenesis in tumor biology and in disciplines as diverse as developmental biology, ophthalmology and dermatology.
His laboratory reported the first purified angiogenesis molecule, the first angiogenesis inhibitor and proposed the concept of angiogenic disease. All of these discoveries have been translated into numerous clinical trials. Angiogenesis inhibitors are now approved by the FDA in the U.S., and in 28 other countries.
Largely because of Dr. Folkman’s research, the possibility of antiangiogenic therapy is now on a firm scientific foundation, not only in the treatment of cancer, but of many non-neoplastic diseases as well, including diseases of the eye.
|